| scholarly article | Q13442814 |
| P50 | author | Gabriel Rabinovich | Q17987510 |
| Mercedes Fuertes | Q37841931 | ||
| Norberto Zwirner | Q42880727 | ||
| Raúl German Spallanzani | Q49191851 | ||
| Carolina I Domaica | Q56166792 | ||
| Diego O Croci | Q130239211 | ||
| P2093 | author name string | Lucas E Rossi | |
| Andrea Ziblat | |||
| Lara Lapyckyj | |||
| Damián E Avila | |||
| P2860 | cites work | Histone acetyltransferases | Q29547823 |
| Functions of natural killer cells | Q29614300 | ||
| NK cell recognition | Q29615107 | ||
| Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Q29615649 | ||
| Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
| Up on the tightrope: natural killer cell activation and inhibition | Q29619175 | ||
| Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors | Q33697130 | ||
| Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population | Q33928216 | ||
| Polycystic ovarian syndrome in women with epilepsy: a review | Q34345051 | ||
| Histone deacetylase inhibitors in cancer therapy | Q34659283 | ||
| Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors | Q35828771 | ||
| NKG2D function protects the host from tumor initiation | Q36402828 | ||
| NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy | Q36484325 | ||
| Surface NK receptors and their ligands on tumor cells | Q36490899 | ||
| Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy | Q37029357 | ||
| Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect | Q37095317 | ||
| Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas | Q37288403 | ||
| Histone deacetylase inhibitors: a new perspective for the treatment of leukemia | Q37599067 | ||
| Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs | Q37692292 | ||
| Cytokine regulation of natural killer cell effector functions | Q37771915 | ||
| Tumor immunoediting by NKp46. | Q39713057 | ||
| Histone deacetylase inhibitors prevent activation of tumour-reactive NK cells and T cells but do not interfere with their cytolytic effector functions | Q39722163 | ||
| Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells | Q39948537 | ||
| Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity. | Q40000380 | ||
| NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities | Q40053992 | ||
| Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. | Q40084538 | ||
| Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells | Q40108262 | ||
| Histone deacetylase inhibitors suppress natural killer cell cytolytic activity | Q40161252 | ||
| Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation | Q40278633 | ||
| Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. | Q40344948 | ||
| Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity | Q40778493 | ||
| Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. | Q43143715 | ||
| Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis | Q44897188 | ||
| Translocation-positive acute myeloid leukemia associated with valproic acid therapy | Q44926636 | ||
| HDAC6 expression is correlated with better survival in breast cancer. | Q45122014 | ||
| Cancer risk in long-term users of valproate: a population-based case-control study. | Q45977880 | ||
| HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. | Q46017171 | ||
| Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate | Q46158181 | ||
| Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis? | Q46408704 | ||
| HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha | Q46541460 | ||
| Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate | Q46604673 | ||
| Deacetylase inhibition promotes the generation and function of regulatory T cells. | Q46961808 | ||
| Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. | Q51833288 | ||
| Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. | Q52005889 | ||
| Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils. | Q53455289 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 321-331 | |
| P577 | publication date | 2011-11-28 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression | |
| P478 | volume | 91 |
| Q47231337 | ---Inhibition of histone H3K27 demethylase selectively modulates inflammatory phenotypes of natural killer cells. |
| Q57821545 | Aberrant O-glycosylation modulates aggressiveness in neuroblastoma |
| Q38203261 | Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity |
| Q27329648 | Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids |
| Q37995939 | Combining immunotherapy and targeted therapies in cancer treatment |
| Q38749824 | Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy |
| Q38225708 | Epigenetic drug discovery for Alzheimer's disease |
| Q39456708 | Epigenetic drugs for Alzheimer's disease: hopes and challenges. |
| Q36853857 | Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid |
| Q39090345 | Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation |
| Q85263415 | Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics |
| Q64093968 | Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells |
| Q42380131 | Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells |
| Q64100189 | Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency |
| Q38763747 | Histone deacetylase inhibitors as immunomodulators in cancer therapeutics |
| Q61625312 | IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness |
| Q34935239 | Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine |
| Q36110266 | Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells |
| Q39156647 | Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. |
| Q38734336 | Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma |
| Q49191767 | Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation. |
| Q38762340 | NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells. |
| Q28080823 | NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma |
| Q37743484 | Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma. |
| Q42796257 | New prospects on the NKG2D/NKG2DL system for oncology |
| Q36211604 | Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study |
| Q38073760 | Novel immune modulators used in hematology: impact on NK cells |
| Q55514827 | Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation. |
| Q38829849 | Targeting natural killer cells in cancer immunotherapy |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q37719306 | The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. |
| Q41664041 | Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes |
| Q38988078 | Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy. |
| Q100750424 | Valproic acid inhibits interferon-γ production by NK cells and increases susceptibility to Listeria monocytogenes infection |
Search more.